OEL Fastrac catalog listing now available as a RSS feed

Affygility Solutions is pleased to announce that its OEL Fastrac catalog listing is now available as a RSS (Really Simple Syndication) feed. Listed below is an example of the feed displaying that latest six occupational exposure limit (OEL) with ADE monographs. Click on the compound name heading to go directly to the specific OEL/ADE monograph product page.

  • Aceclofenac


    Aceclofenac use for the relief of pain and inflammation in osteoarthritis, rheumatoid arthritis and arthritis of the spine. Aceclofenac is a non-steroidal anti-inflammatory drug that inhibits prostaglandin synthesis.

    Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.

    The OEL Fastrac monograph for Aceclofenac is available for purchase for $639 USD.

  • Lenvatinib


    Lenvatinib, a kinase inhibitor, is indicated for the treatment of thyroid and kidney cancer. Lenvatinib is a receptor tyrosine kinase (RTK) inhibitor that inhibits the kinase activities of vascular endothelial growth factor (VEGF) receptors VEGFR1, VEGFR2, and VEGFR3, and other RTKs that are implicated in abnormal growth of blood vessels, tumor growth, and cancer progression.

    Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.

    The OEL Fastrac monograph for Lenvatinib is available for purchase for $639 USD.

  • Butorphanol


    Butorphanol is used to relieve mild to severe pain (analgesic) where the use of an opioid analgesic is appropriate. Butorphanol is a mixed agonist-antagonist with low intrinsic activity at receptors of the μ- opioid type (morphine-like). Its interactions with these receptors in the central nervous system mediate most of its pharmacologic effects, including analgesia.

    Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.

    The OEL Fastrac monograph for Butorphanol is available for purchase for $639 USD.

  • Oxcarbazepine


    Oxcarbazepine is a mood stabilizing and anticonvulsant drug. The pharmacological activity of oxcarbazepine is primarily exerted through the 10- monohydroxy metabolite (MHD) of oxcarbazepine. The exact mechanism of action is not clear but oxcarbazepine and MHD appear to reduce seizures by decreasing abnormal electrical activity in the brain.

    Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.

    The OEL Fastrac monograph for Oxcarbazepine is available for purchase for $639 USD.

  • Plerixafor


    Plerixafor is indicated for the harvesting of peripheral blood stem cells for patients with non- Hodgkin lymphoma (blood cancer) and multiple myeloma (cancer of plasma cells). Plerixafor is a hematopoietic stem cell mobilizer which inhibits the CXCR4 chemokine receptor and blocks binding of its ligand, stromal cell-derived factor-1-alpha (SDF-1-alpha) which results in increased white blood cells and elevations in circulating stem cells.

    Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.

    The OEL Fastrac monograph for Plerixafor is available for purchase for $639 USD.

  • Fluticasone Propionate


    Fluticasone propionate is indicated for the treatment seasonal allergies, asthma and inflammation and itchiness of the skin. Fluticasone propionate is a corticosteroid with anti-inflammatory activity. Inflammation is a contributing factor to allergies, asthma and some types of skin irritation.

    Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.

    The OEL Fastrac monograph for Fluticasone Propionate is available for purchase for $639 USD.

If you wish to add the feed to a feed reader, here’s the link: http://affygility.com/oel/feed.xml


mm

About Dean Calhoun

view all posts

Dean is the President and CEO of Affygility Solutions. Affygility Solutions provides environmental, health and safety software, potent compound safety, industrial hygiene, containment validation services to the pharmaceutical, biotechnology, and medical device industry. "Dean's Google+ Profile"

Affygility Solutions - provider of potent compound safety, webinars, and compliance management software